期刊文献+

骨保护素/核因子-κB受体活化因子配体/核因子-κB受体活化因子信号通路与骨质疏松的研究进展 被引量:6

Stress Sensitive Signal Pathway Osteoprotegerin/Receptor Activator of Nuclear Factor-κB ligand/Receptor Activator of Nuclear Factor-κB and Osteoporosis(review)
下载PDF
导出
摘要 运动对骨质疏松症有积极作用,但其治疗的分子生物学机制仍未清楚。骨保护素/核因子-κB受体活化因子配体/核因子-κB受体活化因子(OPG/RANKL/RANK)信号通路的发现,有助于骨质疏松症的治疗。机械应力可以调节OPG/RANKL/RANK信号通路,参与预防和治疗骨质疏松进程。本文就应力敏感信号通路OPG/RANKL/RANK与骨质疏松的关系进行综述。 Exercise is benefic for osteoporosis, without clear molecular biology mechanism. The osteoprotegerin/receptor activator of nuclear factor-κB ligand/receptor activator of nuclear factor-κB (OPG/RANKL/RANK) signal pathway contributes to osteoporosis, which can be mediated by mechanical force. Research progress on osteoporosis and the stress sensitive signal pathway OPG/RANKL/RANK were reviewed in this paper.
出处 《中国康复理论与实践》 CSCD 北大核心 2014年第3期250-252,共3页 Chinese Journal of Rehabilitation Theory and Practice
基金 江苏省2012年度普通高校研究生科研创新计划项目(No.CXZZ12_0787)
关键词 骨质疏松症 应力 骨保护素 核因子-ΚB受体活化因子配体 核因子-κB受体活化因子 信号通路 综述 osteoporosis stress osteoprotegerin receptor activator of nuclear factor-κB ligand receptor activator of nuclear factor-κB signal pathway review
  • 相关文献

参考文献43

  • 1孔祥鹤,牛银波,李宇华,梅其炳.OPG/RANK/RANKL系统与骨质疏松研究最新进展[J].生命科学研究,2011,15(1):80-85. 被引量:28
  • 2Wright HL, Mccarthy HS, Middleton J, et al. RANK, RANKL and os- teoprotegerin in bone biology and disease [J]. Curr Rev Musculoskelet Med, 2009, 2(1): 56-64.
  • 3Nakamura M, Udagawa N. Osteoporosis and RANKL signal [J]. Clin Calcium, 2011, 21(8): 1149-1155.
  • 4Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone model- ing and remodeling [J]. Arch Biochem Biophys, 2008, 473(2): 139-146.
  • 5Yamaguchi M. RANK/R.ANKL/OPG during orthodontic tooth move- merit [J]. Orthod Craniofac Res, 2009, 12(2): 113-119.
  • 6Harada S, Takahashi N. Control of bone resorption by RANKL-RANK system [J]. Clin Calcium, 2011, 21(8): 1121-1130.
  • 7Narducci P, Bareggi R, Nicolin V. Receptor activator for nuclear factor kappa B ligand (RANKL) as an osteoimmune key regulator in bone physiology and pathology [J]. Acta Histochemica, 2011, 113 (2): 73-81.
  • 8Dempster DW, Lambing CL, Kostenuik P J, et al. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data [J]. Clin Ther, 2012, 34(3): 521-536.
  • 9Coluzzi F, Di Bussolo E, Mandatori I, et al. Bone metastatic disease: taking aim at new therapeutic targets [J]. Curr Med Chem, 2011, 18 (20): 3093-3115.
  • 10Anastasia P, Ioannis P, Kelly M, et al. High levels of synovial fluid os- teoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor- r.B ligand (RANKL) to OPG correlate with disease se- verity in patients with primary knee osteoarbritis [J]. Clin Biochem, 2008, 41(9): 746-749.

二级参考文献98

  • 1秦岭,陈启明,梁国穗.体育运动与骨骼——骨密度和结构与生物力学适应性[J].中国运动医学杂志,2004,23(5):532-536. 被引量:22
  • 2黄良夫,毕大卫.性激素-原发性骨质疏松症-治疗进展[J].浙江临床医学,2005,7(12):1233-1234. 被引量:5
  • 3丁明晖,黄东锋,李燕,蒋伶俐.运动对骨密度的影响[J].中国骨质疏松杂志,2006,12(1):80-81. 被引量:15
  • 4许勇,杨桦,乔建瓯,李西华,严兰珍,王龙,徐国江,费俭,傅继粱,王铸钢.骨保护素(Opg)基因敲除小鼠发生高转换型骨质疏松和动脉钙化(英文)[J].生物化学与生物物理进展,2007,34(3):260-266. 被引量:26
  • 5DE MARTINIS M,DI BENEDETTO M C,MENGOLI L P,et al.Senile osteoporosis:is it an immune-mediated disease[J].Inflammation Research,2006,55(10):399-404.
  • 6DEAL C.Potential new drug targets for osteoporosis[J].Nature Clinical Practice Rheumatology,2009,5(3):20-27.
  • 7SIMONET W S,LACEY D L,DUNSTAN C,et al.Osteoprotegerin:A novel secreted protein involved in the regulation of bone density[J].Cell,1997,89(2):309-319.
  • 8GORI F,HOFBAUER L C,DUNSTAN C R,et al.The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated[J].Endocrinology,2000,141(12):4768-4776.
  • 9WADA T,NAKASHIMA T,HIROSHI N,et al.RANKLRANK signaling in osteoclastogenesis and bone disease[J].Trends in Molecular Medicine,2006,12(1):17-25.
  • 10ANN E K,SUNDEEP K,PAUL K.RANKL and OPG regulation of bone remodeling in health and disease[J].Endocrine Reviews,2008,29(2):155-192.

共引文献89

同被引文献64

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部